Updates are available Correction dated 2022-02-13
Click to view Correction: https://doi.org/10.1007/s10147-022-02137-5
-
Authors
Tozawa, Akiko
Kimura, Fuminori
Takai, Yasushi
Nakajima, Takeshi
Ushijima, Kimio
Kobayashi, Hiroaki
Satoh, Toyomi
Harada, Miyuki
Sugimoto, Kohei
Saji, Shigehira
Shimizu, Chikako
Akiyama, Kyoko
Bando, Hiroko
Kuwahara, Akira
Furui, Tatsuro
Okada, Hiroshi
Kawai, Koji
Shinohara, Nobuo
Nagao, Koichi
Kitajima, Michio
Suenobu, Souichi
Soejima, Toshinori
Miyachi, Mitsuru
Miyoshi, Yoko
Yoneda, Akihiro
Horie, Akihito
Ishida, Yasushi
Usui, Noriko
Kanda, Yoshinobu
Fujii, Nobuharu
Endo, Makoto
Nakayama, Robert
Hoshi, Manabu
Yonemoto, Tsukasa
Kiyotani, Chikako
Okita, Natsuko
Baba, Eishi
Muto, Manabu
Kikuchi, Iwaho
Morishige, Ken-ichirou
Tsugawa, Koichiro
Nishiyama, Hiroyuki
Hosoi, Hajime
Tanimoto, Mitsune
Kawai, Akira
Sugiyama, Kazuhiko
Boku, Narikazu
Yonemura, Masato
Hayashi, Naoko
Aoki, Daisuke
Suzuki, Nao http://orcid.org/0000-0002-7440-8127
Osuga, Yutaka
- License Information
-
More Information
Article History
Received: 25 October 2021
Accepted: 7 November 2021
First Online: 13 January 2022
Change Date: 13 February 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10147-022-02137-5
Declarations
:
: Members of the Guideline Review Committee behaved in accordance with the Japanese Society of Clinical Oncology (JSCO) Guidelines for Conflict of Interest Issues Related to Clinical Studies of Oncology. Potential conflicts of interest of individual committee members are declared at ExternalRef removed. Development of these guidelines was funded by the JSCO. Neither the opinions nor the interests of the funding body (JSCO) affected the final guideline recommendations.
